{'fraction_non_alphanumeric': 0.014722536806342015, 'fraction_numerical': 0.0, 'mean_word_length': 6.015873015873016, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Melanoma Staging: A Review of the Revised American Joint Committee on Cancer Guidelines

ABSTRACT Proper staging of melanoma is crucial to defining prognosis and subsequent recommendations for treatment and follow-up care. Two components of melanoma staging include pathological and clinical staging. Pathological staging includes microstaging of the tumor itself and pathological information about the regional lymph nodes, whereas clinical staging incorporates the microstaging of the primary tumor as well as clinical and radiological evaluation for metastasis. To educate patients about their individual diagnosis, prognosis, and follow-up recommendations, dermatology nurses must understand these differences in staging as well as the specific factors that comprise each category of the American Joint Committee on Cancer tumor-node-metastasis classification and staging system.